Introduction: Zoledronic acid (ZOL), a nitrogen containing bisphosphonate, has been shown in vitro to inhibit osteoclastic activity and to regulate cell proliferation, differentiation and gene expression in osteoblasts (Greiner et al. 2006; Greiner et al. 2007). Because of its impact on bone cells there might be a possible benefit in treatment of fractures by local application of this potent substance. A local application from a biodegradable Poly(D,L-Lactide) (PDLLA) coating of osteosynthetic implants might lead to a stimulating effect on fracture healing. Aim of the study was to analyze the effect of locally applied ZOL from a PDLLA coating of intramedullary implants on fracture healing.
